[Cyclic idiopathic edema syndrome. 3. Biological studies. Physiopathological and therapeutic deductions].
D000293:Adolescent; D000308:Adrenocortical Hyperfunction / Q000150:complications; D000328:Adult; D002199:Capillary Permeability; D004231:Diuresis; D004232:Diuretics / Q000009:adverse effects; D004487:Edema / Q000503:physiopathology* / Q000628:therapy; D004573:Electrolytes / Q000378:metabolism; D004702:Endocrine Glands / Q000503:physiopathology; D005260:Female; D005419:Flavonoids / Q000627:therapeutic use; D005919:Glomerular Filtration Rate; D005951:Glucose Tolerance Test; D006801:Humans; D006929:Hyperaldosteronism / Q000150:complications; D008875:Middle Aged; D000451:Mineralocorticoid Receptor Antagonists; D013566:Sympathomimetics / Q000627:therapeutic use; D014882:Water-Electrolyte Balance
D004232:Diuretics; D004573:Electrolytes; D005419:Flavonoids; D000451:Mineralocorticoid Receptor Antagonists; D013566:Sympathomimetics
Le syndrome d'oedèmes cycliques idiopathiques. 3. Etudes biologiques. Déductions physiopathologiques et thérapeutiques.